Cardiac adrenoceptors: physiological and pathophysiological relevance

OE Brodde, H Bruck, K Leineweber - Journal of pharmacological …, 2006 - jstage.jst.go.jp
At present, nine adrenoceptor (AR) subtypes have been identified: α1A-, α1B-, α1D-, α2A-,
α2B-, α2C-, β1-, β2-, and β3AR. In the human heart, β1-and β2AR are the most powerful …

β-Adrenergic receptor subtype signaling in heart: from bench to bedside

AYH Woo, R Xiao - Acta Pharmacologica Sinica, 2012 - nature.com
Abstract β-adrenergic receptor (βAR) stimulation by the sympathetic nervous system or
circulating catecholamines is broadly involved in peripheral blood circulation, metabolic …

[HTML][HTML] Left ventricular assist device and drug therapy for the reversal of heart failure

EJ Birks, PD Tansley, J Hardy, RS George… - … England Journal of …, 2006 - Mass Medical Soc
Background In patients with severe heart failure, prolonged unloading of the myocardium
with the use of a left ventricular assist device has been reported to lead to myocardial …

Cardioprotection by intermittent fasting in rats

I Ahmet, R Wan, MP Mattson, EG Lakatta, M Talan - Circulation, 2005 - Am Heart Assoc
Background—Intermittent fasting (IF), a dietary regimen in which food is available only every
other day, increases the life span and reduces the incidence of age-associated diseases in …

Myocardial adeno-associated virus serotype 6–βARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure

G Rengo, A Lymperopoulos, C Zincarelli… - Circulation, 2009 - Am Heart Assoc
Background—The upregulation of G protein–coupled receptor kinase 2 in failing
myocardium appears to contribute to dysfunctional β-adrenergic receptor (βAR) signaling …

Cardioprotection, attenuated systemic inflammation, and survival benefit of β1-adrenoceptor blockade in severe sepsis in rats

GL Ackland, ST Yao, A Rudiger, A Dyson… - Critical care …, 2010 - journals.lww.com
Objective: To explore the hypothesis that beta-1 adrenoreceptor blockade may be protective
through the attenuation of sympathetic hyperactivity and catecholaminergic inflammatory …

Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue

ST Pleger, P Most, M Boucher, S Soltys, JK Chuprun… - Circulation, 2007 - Am Heart Assoc
Background—The incidence of heart failure is ever-growing, and it is urgent to develop
improved treatments. An attractive approach is gene therapy; however, the clinical barrier …

Subtype-specific α1-and β-adrenoceptor signaling in the heart

RP Xiao, W Zhu, M Zheng, C Cao, Y Zhang… - Trends in …, 2006 - cell.com
Recent studies of adrenoceptors have revealed subtype-specific signaling, promiscuous G-
protein coupling, time-dependent switching of intracellular signaling pathways …

Ca2+ Cycling and New Therapeutic Approaches for Heart Failure

AM Lompré, RJ Hajjar, SE Harding, EG Kranias… - Circulation, 2010 - Am Heart Assoc
Heart failure (HF) is a major health problem in Western countries. Despite significant
progress in pharmacological and device-based treatment, the disease burden imposed …

Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart diseases

VM Costa, F Carvalho, ML Bastos… - Current medicinal …, 2011 - ingentaconnect.com
Pathologic heart conditions, particularly heart failure (HF) and ischemia-reperfusion (I/R)
injury, are characterized by sustained elevation of plasma and interstitial catecholamine …